The Cigna Group (CI)
The Cigna Group (CI) carries a ŷRobot AI score of 64 out of 100. The model's fair value estimate is $307.55, 3.5% above the last close of $297.15. The chart signal reads Bearish.
| Metric | CI |
|---|---|
| AI score | 64 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $307.55 |
| Upside to fair value | 3.5% |
| Previous close | $297.15 |
| P/E | 12.94 |
| Price / sales | 0.27 |
| Market cap | $78.07B |
| EPS | 22.68 |
| Revenue growth | 14.9% |
| 1-year price change | 2.7% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about CI
Is CI overvalued or undervalued right now?
As of Nov 9, 2026, ŷRobot's fair-value model estimates The Cigna Group (CI) at $307.55 against a last close of $297.15, implying 3.5% upside to the model's estimate.
Is CI's chart signal bullish or bearish?
The chart-signal model classifies CI as Neutral as of Nov 13, 2026, with a signal score of -0.08 on a -1 to 1 scale.
What is CI's ŷRobot AI score?
CI scores 64 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is CI stock expensive on P/E and P/S?
CI trades at 12.9 times earnings and 0.3 times sales as of Nov 13, 2026.
What does CI's seasonal forecast show?
ŷRobot's seasonal forecast curve for CI reads +0.4% at 30 days, +0.9% at 90 days, and +2.7% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is CI growing?
The Cigna Group's revenue growth is +14.9% and free-cash-flow growth is -0.4% on the latest reported figures.
CI chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.